Itai Glinert
Overview
Explore the profile of Itai Glinert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
502
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sittner A, Bar-David E, Glinert I, Ben-Shmuel A, Schlomovitz J, Levy H, et al.
Pathogens
. 2024 Nov;
13(11).
PMID: 39599489
Anthrax is a fatal zoonotic disease caused by exposure to spores. The CDC's guidelines divide anthrax treatment into three categories according to disease progression: post-exposure prophylaxis (PEP), systemic, and systemic...
2.
Ben-Shmuel A, Glinert I, Sittner A, Bar-David E, Schlomovitz J, Levy H, et al.
Antimicrob Agents Chemother
. 2024 Apr;
68(6):e0161023.
PMID: 38687017
Efficient treatment of anthrax-related meningitis in patients poses a significant therapeutic challenge. Previously, we demonstrated in our anthrax meningitis rabbit model that ciprofloxacin treatment is ineffective with most of the...
3.
Boby M, Fearon D, Ferla M, Filep M, Koekemoer L, Robinson M, et al.
Science
. 2023 Nov;
382(6671):eabo7201.
PMID: 37943932
We report the results of the COVID Moonshot, a fully open-science, crowdsourced, and structure-enabled drug discovery campaign targeting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease. We discovered...
4.
Glinert I, Bar-David E, Ben-Shmuel A, Sittner A, Puni R, Laredo S, et al.
PLoS One
. 2023 Feb;
18(2):e0281879.
PMID: 36795682
Bacillus anthracis overcomes host immune responses by producing capsule and secreting toxins. Production of these virulence factors in response to entering the host environment was shown to be regulated by...
5.
Makdasi E, Atiya-Nasagi Y, Gur D, Glinert I, Shmaya S, Milrot E, et al.
Microbiol Spectr
. 2022 Oct;
10(5):e0241522.
PMID: 36190401
The life-threatening disease tularemia is caused by Francisella tularensis, an intracellular Gram-negative bacterial pathogen. Due to the high mortality rates of the disease, as well as the low respiratory infectious...
6.
Glinert I, Ben-Shmuel A, Szwartcwort-Cohen M, Beth-Din A, Laskar O, Barlev-Gross M, et al.
Int J Infect Dis
. 2022 Mar;
118:211-213.
PMID: 35257907
SARS-CoV-2 Omicron strain emergence raised concerns that its enhanced infectivity is partly due to altered spread/contamination modalities. We therefore sampled high-contact surfaces and air in close proximity to patients who...
7.
Fisher M, Manor A, Abramovitch H, Fatelevich E, Afrimov Y, Bilinsky G, et al.
Anal Chem
. 2022 Mar;
94(10):4380-4389.
PMID: 35230823
A multi-component microarray, applying a novel analysis algorithm, was developed for quantitative evaluation of the SARS-CoV-2 vaccines' immunogenicity. The array enables simultaneous quantitation of IgG, IgM, and IgA, specific to...
8.
Makdasi E, Atiya-Nasagi Y, Gur D, Zauberman A, Schuster O, Glinert I, et al.
Pathogens
. 2022 Feb;
11(2).
PMID: 35215198
Plague, caused by the human pathogen , is a severe and rapidly progressing lethal disease that has caused millions of deaths globally throughout human history and still presents a significant...
9.
Yahalom-Ronen Y, Erez N, Fisher M, Tamir H, Politi B, Achdout H, et al.
Vaccines (Basel)
. 2022 Feb;
10(2).
PMID: 35214749
The emergence of rapidly spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a major challenge to the ability of vaccines and therapeutic antibodies to provide immunity. These...
10.
Madar-Balakirski N, Rosner A, Melamed S, Politi B, Steiner M, Tamir H, et al.
Arch Toxicol
. 2022 Jan;
96(3):859-875.
PMID: 35032184
rVSV-ΔG-SARS-CoV-2-S is a clinical stage (Phase 2) replication competent recombinant vaccine against SARS-CoV-2. To evaluate the safety profile of the vaccine, a series of non-clinical safety, immunogenicity and efficacy studies...